Skip to main content

Executive summary

2024 Star ratings preview

Navigate a return to normal and the path forward. 

Stars performance is in your control

Focus on key actions to manage Stars performance through enhanced member engagement. Read the executive summary to learn how you can take control now.

Related healthcare insights

Report

A simpler GLP-1, plus big-market launches

This edition of Notable New Drugs includes another oral GLP-1, the first preventative treatment for COVID-19 and the most effective oral drug for plaque psoriasis.

White paper

Building a framework to support value-based care

Discover how your health plan can strengthen its risk adjustment programs with Optum.

White paper

Drive improved outcomes and lower costs for blood cancers with CAR T therapy

This white paper analyzes CAR T utilization, outcomes and economic impact across commercial and Medicare populations in the Optum Cell and Gene Therapy (CGT) program from 2022–2024.